Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / COM
-
Number of holders
-
182
-
Total 13F shares, excl. options
-
49.1M
-
Shares change
-
-418K
-
Total reported value, excl. options
-
$2.67B
-
Value change
-
-$6.24M
-
Put/Call ratio
-
0.22
-
Number of buys
-
85
-
Number of sells
-
-87
-
Price
-
$54.44
Significant Holders of Biohaven Pharmactl Hldg Co L - COM (BHVN) as of Q4 2019
235 filings reported holding BHVN - Biohaven Pharmactl Hldg Co L - COM as of Q4 2019.
Biohaven Pharmactl Hldg Co L - COM (BHVN) has 182 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 49.1M shares
.
Largest 10 shareholders include Capital International Investors (2.92M shares), BlackRock Inc. (2.92M shares), STIFEL FINANCIAL CORP (2.84M shares), RP Management, LLC (2.11M shares), ORACLE INVESTMENT MANAGEMENT INC (1.92M shares), STATE STREET CORP (1.91M shares), Capital World Investors (1.65M shares), EVENTIDE ASSET MANAGEMENT, LLC (1.63M shares), ALLIANCEBERNSTEIN L.P. (1.61M shares), and WELLINGTON MANAGEMENT GROUP LLP (1.54M shares).
This table shows the top 182 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.